Carlberg, B., Samuelsson, O., Lindholm, L. H. et al. In hypertension: Is it a wise choice? Lancet, 364:1684–89, 2004.
Devereux, R. B. Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy? Circulation, 95:1983–85, 1997.
Gottdiener, J. S., Reda, D. J., Massie, B. M. et al. For the VA Corporative Study group on antihypertensive agents. Effects of single drug therapy on reduction of left ventricular mass in mild to moderate hyper¬tension: Comparison of six antihypertensive agents. Circulation, 95:2007–14, 1997.
Harda, K., Komuro, I., Shiojima, I. et al. Pressure overload induces cardiac hypertrophy in angiotensin II type Ia receptor knock–out mice. Circulation, 97:1952–1959, 1998.
Mattioli, A. V., Zennaro, M., Bonatti, S. et al. Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan. Int. J. Cardiol., 97: Issue 3, 383–388, 2004.
Pitt, B. Regression of left ventricular hypertrophy in patients with hypertension. Blockade of the renin angiotensin aldosterone system. Circulation, 98:1987–89, 1998.
Pitt, B., Reichek, N., Willenbrock, R. et al. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hyperten¬sion and left ventricular hypertrophy: The 4E-left ventricular hypertrophy study. Circulation, 108:1831–1838, 2003.

Страницы: 1 | 2